- Trials with a EudraCT protocol (26,258)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9,945)
26,258 result(s) found for: NA.
Displaying page 38 of 1,313.
EudraCT Number: 2005-003505-85 | Sponsor Protocol Number: FHED-01 ANZ0009 | Start Date*: 2005-10-07 |
Sponsor Name:Dermal Laboratories Limited | ||
Full Title: 4head User Evaluation. | ||
Medical condition: Tension-type headaches. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003861-34 | Sponsor Protocol Number: 0/2004 | Start Date*: 2005-06-08 |
Sponsor Name:Department of Nuclear Medicine | ||
Full Title: Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects | ||
Medical condition: There is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the de... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002455-13 | Sponsor Protocol Number: TCW-01-04 | Start Date*: 2004-12-30 |
Sponsor Name:Dept. of Internal Medicine | ||
Full Title: Vergleich der Effektivität von Insulin Aspart und Normalinsulin bei Typ 2 Diabetikern hinsichtlich des postprandialen Stoffwechsels während zwei aufeinanderfolgender Mahlzeiten. Die Huckepack Studie | ||
Medical condition: Type-2 Diabetes treated with insulin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000925-60 | Sponsor Protocol Number: R1/11 | Start Date*: 2011-10-18 |
Sponsor Name:Kungälv Hospital | ||
Full Title: Effect of treatment with methylphenidate on mental fatigue (“brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study. | ||
Medical condition: Mental fatigue after traumatic brain injury or whip-lash injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000436-74 | Sponsor Protocol Number: 432 | Start Date*: 2007-11-27 | |||||||||||
Sponsor Name:Poissy Hospital | |||||||||||||
Full Title: Impact of two glucose control regimens by insulin on hospital mortality in intensive care unit patients (INSUREA Study) | |||||||||||||
Medical condition: hyperglycemia in critical care unit patients | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003903-35 | Sponsor Protocol Number: : NUTH-2005-03384 | Start Date*: 2006-01-19 |
Sponsor Name:Newcastle-upon-Tyne Hospitals NHS Trust | ||
Full Title: : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001231-34 | Sponsor Protocol Number: HTO-OFT-RYC-1 | Start Date*: 2008-06-09 |
Sponsor Name:HOSPITAL UNIVERSITARIO RAMON Y CAJAL | ||
Full Title: Registro de cambios hemodinámicos retrobulbares mediante ecografía doppler color en pacientes con hipertensión ocular ( HTO ) tras tratamiento tópico con Ganfort® ( Bimatoprost / Timolol ). | ||
Medical condition: Conocer el efecto de Bimatoprost/Timolol sobre el flujo sanguíneo ocular (FSO)mediante ecografía doppler color de vasos retrobulbares en pacientes hipertensos oculares. La presión intraocular (PIO)... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001916-22 | Sponsor Protocol Number: Pressure Wire Study | Start Date*: 2008-05-02 |
Sponsor Name:Central Manchester and Manchester Children's Hospital University NHS Trust | ||
Full Title: Study to assess the optimum dose of intravenous adenosine in the assessment of fractional flow reserve | ||
Medical condition: To study the effects of higher dose adenosine on intermediate coronary lesions at coronary angiography which require pressure wire study. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-007319-33 | Sponsor Protocol Number: OP08/8679 | Start Date*: 2009-02-19 |
Sponsor Name:Leeds Teaching Hospitals NHS Trust | ||
Full Title: Do genes predict response to treatment in age-related macular degeneration? | ||
Medical condition: Choroidal neovascularisation secondary to age-related macular degeneration (ARMD) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004719-43 | Sponsor Protocol Number: | Start Date*: 2005-06-30 |
Sponsor Name:University of Cambridge | ||
Full Title: The Effects of 6-Month Administration of a Low Growth Hormone Dose on Insulin Sensitivity, Postload Glucose Tolerance and Cardiovascular Disease Risk Markers in Subjects with Impaired Glucose Toler... | ||
Medical condition: Impaired Glucose Tolerance | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-005313-38 | Sponsor Protocol Number: SOP-386-NEU-005313-38 | Start Date*: 2006-07-17 |
Sponsor Name:Klinikum rechts der Isar, Technical University of Munich | ||
Full Title: Somatostatin_octretide for prevention of rebleeding from gastrointestinal angiodysplasias | ||
Medical condition: study to investigate the efficacy of Octeoid LAR plus standard therapy versus standard therapy alone in patients with bleeding gastrointestinal angiodysplasias | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-004060-24 | Sponsor Protocol Number: Glaucoma Xalacam /Combigan | Start Date*: 2005-11-24 |
Sponsor Name:Department of Clinical Pharmacology | ||
Full Title: A double-masked randomized cross-over study comparing the effect of Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol) fixed combination on intraocular pressure and ocular blood flow ... | ||
Medical condition: Glaucoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001443-29 | Sponsor Protocol Number: A-92-52120-089 | Start Date*: 2004-11-19 |
Sponsor Name:Ipsen Pharma, S.A. | ||
Full Title: A multicentre, randomized, double-blind, parallel and controlled with placebo pilot study to evaluate the efficacy and safety of a single dose of botulinum toxin Type A (Dysport®) associated with r... | ||
Medical condition: Pain caused by primary myofascial syndrome of cervical and dorsal localization | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000021-57 | Sponsor Protocol Number: 01000 | Start Date*: 2006-03-10 |
Sponsor Name:Rigshospitalet | ||
Full Title: Bosentan and Sildenfil for patients with Eisenmenger syndrome | ||
Medical condition: Eisenmengers syndrome is condition with severe pulmonary arterial hypertension due to a shunting of blood from the left side of the heart to the right side of the heart. When the pressure in the pu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001086-17 | Sponsor Protocol Number: 2004UK-001 | Start Date*: 2004-10-19 |
Sponsor Name:Medi-Flex | ||
Full Title: Prospective randomised clinical trial to assess the efficacy of 70% v/v isopropyl alcohol and 2% w/v chlorhexidine in 70% v/v isopyl alcohol for the disinfection of skin prior to peripheral venous ... | ||
Medical condition: This product is a skin disinfectant and therefore is not specific for a medical condition. It will be used where patients require skin disinfection prior to peripheral vascular catheterisation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-005850-22 | Sponsor Protocol Number: 62202-788 | Start Date*: 2008-07-28 | |||||||||||
Sponsor Name:BGDO | |||||||||||||
Full Title: GEMCITABINE AND CETUXIMAB IN PATIENTS WITH ADVANCED OR METASTATIC BILIARY TRACT CANCER: A BGDO MULTICENTER PHASE II STUDY | |||||||||||||
Medical condition: Patients with advanced biliary tract cancer, excluding gallbladder cancer, where surgery is not feasible. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001558-10 | Sponsor Protocol Number: EORTC 20012 | Start Date*: 2004-09-06 |
Sponsor Name:HOSPITAL DE LA SANTA CREU I SANT PAU | ||
Full Title: BEACOPP (4 ciclos escalado + 4 ciclos basal) vs ABDV (8 ciclos) en el linfoma de Hodgkin en estadios III-IV. | ||
Medical condition: Enfermedad de Hodgkin estadios III-IV. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) CZ (Completed) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005093-24 | Sponsor Protocol Number: D791AC00008 | Start Date*: 2005-01-24 |
Sponsor Name:AstraZeneca Österreich GmbH | ||
Full Title: Multicentre, open label, extension study of treatment with gefitinib (IRESSA™) for patients completing other gefitinib clinical studies who may benefit from gefitinib treatment | ||
Medical condition: This trial is for patients with advanced non-small cell lung cancer who have completed a preceding gefitinib trial (ZD1839IL0709 or ZD1839IL0710) and in the opinion of the investigator may benefit ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) HU (Completed) LV (Completed) LT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000419-90 | Sponsor Protocol Number: T-EE05-135 | Start Date*: 2006-06-16 |
Sponsor Name:TAP Pharmaceutical Products Inc. | ||
Full Title: A Phase 3 Study to Evaluate the Safety and Efficacy of TAK-390MR (30 mg QD and 60 mg QD) Compared to Placebo in Maintenance of Healing in Subjects with Healed Erosive Esophagitis | ||
Medical condition: Erosive esophagitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: EE (Completed) HU (Completed) SK (Completed) CZ (Completed) LT (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000859-18 | Sponsor Protocol Number: S308.3.008 | Start Date*: 2006-09-11 |
Sponsor Name:Solvay Pharmaceuticals | ||
Full Title: An open label SLV308 safety extension to study S308.3.003 in early PD patients | ||
Medical condition: Parkinson's Disease Early stage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) EE (Completed) LT (Completed) PT (Completed) IT (Completed) DE (Completed) NL (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
